• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial.

作者信息

Smith Maree T

机构信息

Centre for Integrated Preclinical Drug Development, School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

出版信息

Pain. 2022 Nov 1;163(Suppl 1):S15-S28. doi: 10.1097/j.pain.0000000000002675. Epub 2022 Aug 11.

DOI:10.1097/j.pain.0000000000002675
PMID:35984369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10578428/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/11a15da8800c/jop-163-s15-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/6a410aca3514/jop-163-s15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/fef23e4d3f7e/jop-163-s15-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/af22db84bad2/jop-163-s15-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/bccd14d705c8/jop-163-s15-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/11a15da8800c/jop-163-s15-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/6a410aca3514/jop-163-s15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/fef23e4d3f7e/jop-163-s15-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/af22db84bad2/jop-163-s15-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/bccd14d705c8/jop-163-s15-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72c7/10578428/11a15da8800c/jop-163-s15-g005.jpg

相似文献

1
Nonopioid analgesics discovery and the Valley of Death: EMA401 from concept to clinical trial.非阿片类镇痛药的发现与死亡谷：从概念到临床试验的EMA401
Pain. 2022 Nov 1;163(Suppl 1):S15-S28. doi: 10.1097/j.pain.0000000000002675. Epub 2022 Aug 11.
2
Nonopioid Versus Opioid Analgesics After Thyroid and Parathyroid Surgery: A Systematic Review.甲状腺和甲状旁腺手术后非阿片类镇痛药与阿片类镇痛药的比较：系统评价。
Otolaryngol Head Neck Surg. 2024 Jan;170(1):13-19. doi: 10.1002/ohn.503. Epub 2023 Aug 18.
3
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist.EMA401 的非临床特征描述，一种新型的小分子血管紧张素 II 型受体（AT2R）拮抗剂。
Biopharm Drug Dispos. 2020 Apr;41(4-5):166-183. doi: 10.1002/bdd.2226. Epub 2020 Apr 7.
4
Nonopioid Analgesic Prescriptions Filled after Surgery among Older Adults in Ontario, Canada: A Population-based Cohort Study.加拿大安大略省老年人手术后非阿片类镇痛药处方：一项基于人群的队列研究。
Anesthesiology. 2023 Feb 1;138(2):195-207. doi: 10.1097/ALN.0000000000004443.
5
Nonopioid Analgesics in Postoperative Pain Management After Cardiac Surgery.心脏手术后术后疼痛管理中的非阿片类镇痛药。
Semin Cardiothorac Vasc Anesth. 2021 Dec;25(4):280-288. doi: 10.1177/1089253221998552. Epub 2021 Apr 25.
6
Opioid and Nonopioid Analgesics Provide Similar Relief From Acute Extremity Pain.阿片类和非阿片类镇痛药对急性肢体疼痛的缓解效果相似。
Am J Nurs. 2018 Feb;118(2):69-70. doi: 10.1097/01.NAJ.0000530254.99076.b2.
7
[Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration].[慢性非癌性疼痛中的阿片类药物——阿片类药物优于非阿片类镇痛药吗？对阿片类药物与非阿片类镇痛药至少持续四周的随机直接比较中的疗效、耐受性和安全性的系统评价与荟萃分析]
Schmerz. 2015 Feb;29(1):85-95. doi: 10.1007/s00482-014-1436-0.
8
Risk of asthma exacerbation associated with opioid and nonopioid analgesic use in children with current asthma.哮喘患儿使用阿片类和非阿片类镇痛药与哮喘恶化的风险。
J Manag Care Spec Pharm. 2022 Mar;28(3):325-335. doi: 10.18553/jmcp.2022.28.3.325.
9
Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.阿片类药物与非阿片类药物对慢性背痛或髋部或膝部骨关节炎疼痛患者疼痛相关功能的影响：SPACE随机临床试验
JAMA. 2018 Mar 6;319(9):872-882. doi: 10.1001/jama.2018.0899.
10
Opioid and Nonopioid Analgesic Prescriptions for Dental Visits in the Emergency Department, 2015-2017 National Hospital Ambulatory Medical Care Survey.2015-2017 年国家医院门诊医疗调查：急诊科牙科就诊时开具的阿片类药物和非阿片类药物镇痛处方。
Prev Chronic Dis. 2021 Jun 10;18:E58. doi: 10.5888/pcd18.200571.

引用本文的文献

1
Dopaminergic modulation: revisiting a promising novel pathway for pharmacologic treatment of chronic pain.多巴胺能调节：重新审视慢性疼痛药物治疗的一条有前景的新途径。
Pain. 2025 Apr 25. doi: 10.1097/j.pain.0000000000003598.
2
The angiotensin II type 2 receptor antagonists, PD123,319 ((S-( +)-1-[(4-(dimethylamino)-3-methylphenyl)methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid), EMA300 (5-(2,2-diphenylacetyl)-4-[(4-methoxy-3-methylphenyl)methyl]-1,4,6,7-tetrahydroimidazo[4,5-c]pyridine-6-carboxylic acid) and EMA401 ((3S)-5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), evoke pain relief in a varicella zoster virus-induced rat model of neuropathic pain.血管紧张素II 2型受体拮抗剂PD123319（(S-( +)-1-[(4-(二甲氨基)-3-甲基苯基)甲基]-5-(二苯乙酰基)-4,5,6,7-四氢-1H-咪唑并[4,5-c]吡啶-6-羧酸）、EMA300（5-(2,2-二苯乙酰基)-4-[(4-甲氧基-3-甲基苯基)甲基]-1,4,6,7-四氢咪唑并[4,5-c]吡啶-6-羧酸）和EMA401（(3S)-5-(苄氧基)-2-(2,2-二苯乙酰基)-6-甲氧基-1,2,3,4-四氢异喹啉-3-羧酸），在水痘带状疱疹病毒诱导的大鼠神经性疼痛模型中可减轻疼痛。
Inflammopharmacology. 2025 Mar;33(3):1337-1348. doi: 10.1007/s10787-025-01650-z. Epub 2025 Feb 20.

本文引用的文献

1
Gait analysis as a robust pain behavioural endpoint in the chronic phase of the monoiodoacetate-induced knee joint pain in the rat.步态分析作为大鼠碘乙酸盐诱导的膝关节疼痛慢性期的一种稳健的疼痛行为终点。
Behav Pharmacol. 2022 Feb 1;33(1):23-31. doi: 10.1097/FBP.0000000000000663.
2
Editorial: Verification of Animal Pain Models by Reverse Translation.社论：通过反向翻译验证动物疼痛模型
Front Pharmacol. 2021 Oct 8;12:778880. doi: 10.3389/fphar.2021.778880. eCollection 2021.
3
Autofluorescent imprint of chronic constriction nerve injury identified by deep learning.
3
Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation.作为疼痛靶点的血管紧张素II 2型受体信号传导：实验台、床边研究及反向翻译
Curr Opin Pharmacol. 2023 Dec;73:102415. doi: 10.1016/j.coph.2023.102415. Epub 2023 Dec 1.
4
Targeting sensory neuron GPCRs for peripheral neuropathic pain.针对感觉神经元 G 蛋白偶联受体治疗周围神经性疼痛。
Trends Pharmacol Sci. 2023 Dec;44(12):1009-1027. doi: 10.1016/j.tips.2023.10.003. Epub 2023 Nov 11.
深度学习识别慢性缩窄性神经损伤的自发荧光印记。
Neurobiol Dis. 2021 Dec;160:105528. doi: 10.1016/j.nbd.2021.105528. Epub 2021 Oct 7.
4
Renin-Angiotensin-Aldosterone System and Immunomodulation: A State-of-the-Art Review.肾素-血管紧张素-醛固酮系统与免疫调节：最新综述。
Cells. 2021 Jul 13;10(7):1767. doi: 10.3390/cells10071767.
5
Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.评估甘氨酸转运体 2 抑制剂相对于普瑞巴林、度洛西汀和吲哚美辛在顺铂诱导的周围神经病变大鼠模型中的抗镇痛和抗痛觉过敏疗效。
Biomolecules. 2021 Jun 24;11(7):940. doi: 10.3390/biom11070940.
6
Discovery and Optimization of Highly Potent and Selective ATR Antagonists to Relieve Peripheral Neuropathic Pain.发现并优化高效且选择性的 ATR 拮抗剂以缓解外周神经性疼痛。
ACS Omega. 2021 May 28;6(23):15412-15420. doi: 10.1021/acsomega.1c01866. eCollection 2021 Jun 15.
7
Contribution of colony-stimulating factor 1 to neuropathic pain.集落刺激因子1对神经性疼痛的作用。
Pain Rep. 2021 Mar 9;6(1):e883. doi: 10.1097/PR9.0000000000000883. eCollection 2021.
8
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy.EMA401 在外周神经性疼痛中的疗效和安全性：在带状疱疹后神经痛和糖尿病性神经痛患者中进行的 2 项随机、双盲、2 期研究的结果。
Pain. 2021 Oct 1;162(10):2578-2589. doi: 10.1097/j.pain.0000000000002252.
9
Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019.近年来药物盐的发展：2015 年至 2019 年 FDA 的批准情况。
Drug Discov Today. 2021 Feb;26(2):384-398. doi: 10.1016/j.drudis.2020.11.016. Epub 2020 Nov 19.
10
Blockade of bradykinin receptors or angiotensin II type 2 receptor prevents paclitaxel-associated acute pain syndrome in mice.阻断缓激肽受体或血管紧张素 II 型受体可预防紫杉醇相关的急性痛综合征在小鼠。
Eur J Pain. 2021 Jan;25(1):189-198. doi: 10.1002/ejp.1660. Epub 2020 Oct 6.